Axsome Therapeutics (STU:19X) Days Sales Outstanding : 115.70 (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Axsome Therapeutics Days Sales Outstanding?

Axsome Therapeutics's average Accounts Receivable for the three months ended in Mar. 2025 was €142.5 Mil. Axsome Therapeutics's Revenue for the three months ended in Mar. 2025 was €112.4 Mil. Hence, Axsome Therapeutics's Days Sales Outstanding for the three months ended in Mar. 2025 was 115.70.

The historical rank and industry rank for Axsome Therapeutics's Days Sales Outstanding or its related term are showing as below:

STU:19X' s Days Sales Outstanding Range Over the Past 10 Years
Min: 89.37 Med: 112.06 Max: 275
Current: 109.67

During the past 12 years, Axsome Therapeutics's highest Days Sales Outstanding was 275.00. The lowest was 89.37. And the median was 112.06.

STU:19X's Days Sales Outstanding is ranked worse than
71.33% of 844 companies
in the Biotechnology industry
Industry Median: 70.64 vs STU:19X: 109.67

Axsome Therapeutics's Days Sales Outstanding declined from Mar. 2024 (119.20) to Mar. 2025 (115.70).

Axsome Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Axsome Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axsome Therapeutics Days Sales Outstanding Chart

Axsome Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

275.00

90.12

110.27

Axsome Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															119.20	115.57	108.08	99.53	115.70

Competitive Comparison of Axsome Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, Axsome Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Axsome Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Axsome Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Axsome Therapeutics's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Axsome Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Axsome Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (86.95	+	135.611)	/	2 )	/	368.337	*	365
=	111.2805					/	368.337	*	365
=	110.27

Axsome Therapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (135.611	+	149.293)	/	2 )	/	112.353	*	365 / 4
=	142.452					/	112.353	*	365 / 4
=	115.70

Axsome Therapeutics (STU:19X) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Axsome Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Axsome Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Axsome Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Axsome Therapeutics Inc (STU:19X) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

AXSM:USA 0HKF:UK 19X:Germany

Address

One World Trade Center, 22nd Floor, New York, NY, USA, 10007

Website

https://www.axsome.com

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Axsome Therapeutics Headlines

No Headlines